title: Role of hormonal therapy for prostate cancer: perspective from Japanese experiences.
abstract: Hormonal therapy has been playing an important role in the treatment of prostate cancer. However, it has recently been the subject of criticism that it shows minimal effectiveness, it may reduce patients' quality of life, and induce adverse effects. On the other hand, next-generation hormonal drugs have provided new strategies for hormonal therapy to overcome advanced prostate cancer. Therefore, it is necessary to accumulate further clinical evidence concerning the efficacy and adverse effects of hormonal therapy. And, what is important for the treatment of prostate cancer is how we use hormonal therapy most effectively. This article presents a review of the possible roles of hormonal therapy for prostate cancer based upon experience in Japan.
authors.affiliation: Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
authors.forename: Mikio
authors.initials: M
authors.lastname: Namiki
authors.affiliation: Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
authors.forename: Satoru
authors.initials: S
authors.lastname: Ueno
authors.affiliation: Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
authors.forename: Yasuhide
authors.initials: Y
authors.lastname: Kitagawa
keywords: Adverse effects; hormonal therapy; prostate cancer
references.citation: J Clin Oncol. 2011 May 20;29(15):2040-5
references.pmid: 21502546
references.citation: Lancet. 2010 Apr 24;375(9724):1437-46
references.pmid: 20398925
references.citation: Nat Rev Clin Oncol. 2011 Jan;8(1):12-23
references.pmid: 20859283
references.citation: J Clin Oncol. 2008 May 20;26(15):2497-504
references.pmid: 18413638
references.citation: Int J Urol. 2010 Apr;17(4):337-45
references.pmid: 20202011
references.citation: Lancet. 2009 Jan 24;373(9660):301-8
references.pmid: 19091394
references.citation: Cancer. 2003 Apr 1;97(7):1653-62
references.pmid: 12655522
references.citation: Nihon Rinsho. 2000 Jul;58 Suppl:289-91
references.pmid: 11022731
references.citation: Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1352-9
references.pmid: 15275720
references.citation: J Clin Invest. 2010 Aug;120(8):2715-30
references.pmid: 20644256
references.citation: Lancet. 2002 Jul 13;360(9327):103-6
references.pmid: 12126818
references.citation: Pharmacology. 2010;85(2):110-20
references.pmid: 20130444
references.citation: J Biol Chem. 2012 Feb 3;287(6):3777-87
references.pmid: 22174412
references.citation: Cancer Res. 2004 Jan 15;64(2):765-71
references.pmid: 14744796
references.citation: Cancer Res. 2006 Mar 1;66(5):2815-25
references.pmid: 16510604
references.citation: J Biol Chem. 1993 Aug 25;268(24):18267-71
references.pmid: 8349703
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2420-5
references.pmid: 17557956
references.citation: Urology. 2009 Jun;73(6):1342-6
references.pmid: 19371939
references.citation: Neoplasia. 2012 Jan;14(1):74-83
references.pmid: 22355276
references.citation: Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):789-99
references.pmid: 10386635
references.citation: Anticancer Res. 2010 Dec;30(12):5201-5
references.pmid: 21187513
references.citation: Endocr Rev. 2005 May;26(3):361-79
references.pmid: 15867098
references.citation: Eur Urol. 2000 Dec;38(6):706-13
references.pmid: 11111188
references.citation: JAMA. 2008 Jul 9;300(2):173-81
references.pmid: 18612114
references.citation: Cancer. 2006 Feb 1;106(3):581-8
references.pmid: 16388523
references.citation: BJU Int. 2007 Jan;99 Suppl 1:6-9; discussion 17-8
references.pmid: 17229160
references.citation: Int J Urol. 2005 Jan;12(1):46-61
references.pmid: 15661054
references.citation: Lancet Oncol. 2006 Jun;7(6):472-9
references.pmid: 16750497
references.citation: J Clin Oncol. 2009 Jan 1;27(1):92-9
references.pmid: 19047297
references.citation: BJU Int. 2006 Sep;98(3):573-9
references.pmid: 16925756
references.citation: BMC Cancer. 2012 Mar 22;12:110
references.pmid: 22439742
references.citation: Clin Cancer Res. 2010 Sep 1;16(17):4319-24
references.pmid: 20647476
references.citation: J Urol. 2005 Jun;173(6):1947-52
references.pmid: 15879788
references.citation: Urology. 2002 Jul;60(1):115-9
references.pmid: 12100935
references.citation: Int J Urol. 2006 Dec;13(12):1494-500
references.pmid: 17118024
references.citation: JAMA. 2004 Aug 18;292(7):821-7
references.pmid: 15315996
references.citation: Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):245-6
references.pmid: 9069292
references.citation: J Clin Oncol. 2010 Mar 20;28(9):1496-501
references.pmid: 20159814
references.citation: JAMA. 1998 Sep 16;280(11):969-74
references.pmid: 9749478
references.citation: BJU Int. 2006 Jun;97(6):1190-3
references.pmid: 16686710
references.citation: J Clin Oncol. 2009 Aug 10;27(23):3742-8
references.pmid: 19470933
references.citation: Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1243-52
references.pmid: 11483335
references.citation: Int J Urol. 2004 May;11(5):304-9
references.pmid: 15147546
references.citation: Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):1071-7
references.pmid: 9276374
references.citation: J Natl Cancer Inst. 2003 Jul 2;95(13):981-9
references.pmid: 12837834
references.citation: N Engl J Med. 2009 Jun 11;360(24):2516-27
references.pmid: 19516032
references.citation: Psychooncology. 2002 Sep-Oct;11(5):401-14
references.pmid: 12228873
references.citation: Biochem Biophys Res Commun. 1988 Dec 15;157(2):705-12
references.pmid: 3264499
references.citation: Steroids. 1997 Jan;62(1):148-58
references.pmid: 9029730
references.citation: Nat Clin Pract Urol. 2008 Dec;5(12):648-9
references.pmid: 18936786
references.citation: Endocrinology. 2009 Dec;150(12):5606-16
references.pmid: 19854864
references.citation: Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16759-65
references.pmid: 20823238
references.citation: Int J Urol. 2003 Jul;10(7):377-82
references.pmid: 12823692
references.citation: J Urol. 2008 Sep;180(3):921-7
references.pmid: 18635218
references.citation: Mol Endocrinol. 1991 Oct;5(10):1373-80
references.pmid: 1723139
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4448-56
references.pmid: 16983113
references.citation: Cancer. 2006 Sep 15;107(6):1265-72
references.pmid: 16900523
references.citation: Cancer. 2009 Aug 1;115(15):3437-45
references.pmid: 19536889
references.citation: J Clin Oncol. 2009 May 1;27(13):2137-43
references.pmid: 19307511
references.citation: Int J Urol. 2007 May;14(5):416-21
references.pmid: 17511724
references.citation: Oncology (Williston Park). 2008 Aug;22(9):995-1004; discussion 1006, 1011-7
references.pmid: 18777953
references.citation: Science. 2009 May 8;324(5928):787-90
references.pmid: 19359544
references.citation: J Urol. 2011 May;185(5):1674-80
references.pmid: 21419449